CClinicalTrials.gg
CompletedNCT05502328Updated Nov 22, 2023

Radicle Energy: A Study of Cannabinoids on Energy and Other Health Outcomes

An interventional study of Energy Study Product Usage in Energy, sponsored by Radicle Science. Completed at 1 site in United States. Open to participants aged 21 Years to 105 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-22.

Sponsored by Radicle Science · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
1,427
Allocation
Randomized
Ages
21 Years to 105 Years
Sex
All
01

Study summary

A randomized, blinded, placebo-controlled study of cannabinoid formulations and their effects on energy levels, focus, appetite and other health outcomes

Read the detailed description

This is a randomized, blinded, placebo-controlled study conducted with up to 300 adult participants per study arm (3000 total), age 21 and older and residing in the United States.

Eligible participants will (1) endorse a desire for more energy (less fatigue and/or better concentration/focus during screening); (2) indicate a willingness to refrain from taking cannabinoids during the study period, and (3) indicate an interest in taking a plant derived cannabinoid product to help with their energy and/or focus.

Participants with known liver disease, heavy drinkers, and those who are pregnant, trying to become pregnant, or breastfeeding will be excluded. Those taking medications that warn against grapefruit consumption will be excluded. People with a calculated BMI of 18.5 or less will be excluded.

Self-reported data are collected electronically from eligible participants over 5 weeks. Participant reports of health indicators will be collected during baseline, throughout the active period of study product use, and in a final survey. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study.

02

Conditions studied

  • Energy
03

In context

Lead sponsor

Radicle Science is the lead sponsor of 64 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 105 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 21 years of age and older
  • Resides in the United States
  • Endorses: a desire for more energy (less fatigue) and/or a desire for better concentration (focus/attention)
  • Selects more energy and/or better concentration as a primary reason for taking a cannabinoid product
  • Expresses a willingness to refrain from taking any non-study cannabinoid product (i.e.

CBD, THC) for the duration of participant engagement

  • Expresses a willingness to take a study product and not knowing the product identity until the end of the study

Exclusion criteria

Exclusion Criteria:

Pregnant, trying to become pregnant, or breastfeeding Reports a diagnosis of liver disease Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day) Unable to read and understand English Lack of reliable daily access to the internet Reports taking any medication that warns against grapefruit consumption Calculated BMI 18.5 or less

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
1,427 participants (actual)

Study arms

  • Placebo comparator
    Control 1

    Energy Product Form 1 - control

    Dietary Supplement: Energy Study Product Usage

  • Placebo comparator
    Control 2

    Energy Product Form 2 - control

    Dietary Supplement: Energy Study Product Usage

  • Experimental
    Energy Product 1.1

    Energy Product Form 1 - active product 1

    Dietary Supplement: Energy Study Product Usage

  • Experimental
    Energy Product 1.2

    Energy Product Form 1 - active product 2

    Dietary Supplement: Energy Study Product Usage

  • Experimental
    Energy Product 2.1

    Energy Product Form 2 - active 1

    Dietary Supplement: Energy Study Product Usage

  • Experimental
    Energy Product 2.2

    Energy Product Form 2 - active 2

    Dietary Supplement: Energy Study Product Usage

Interventions

  • Dietary supplementEnergy Study Product Usage

    Participants will use their Radicle Energy study product as directed for a period of 4 weeks.

06

What researchers measure

Primary outcomes

  1. Change in energy

    Change in mean energy score as assessed by Patient Reported Outcome Measurement System (PROMIS) Fatigue 7a (scale 1-5; where lower score is less fatigue)

    Time frame: 4 weeks

  2. Change in focus

    Change in concentration (ability to focus) score as assessed by PROMIS™ Cognition 6a (scale 1-5; where lower score is worse focus (cognitive function))

    Time frame: 4 weeks

Secondary outcomes

  1. Change in energy (measure 2)

    Change in energy level score as assessed by a visual analog scale (VAS; Scoring from 0 to 10, with 0 being 'No energy' and 10 being 'More than enough energy')

    Time frame: 4 weeks

  2. Change in body weight

    Change in body weight as assessed by self-reported body weight in pounds

    Time frame: 4 weeks

  3. Change in appetite

    Change in appetite as assessed by a visual appetite scale (VAS; Scoring from 0 to 10, with 0 being 'No hunger' and 10 being 'Always hungry')

    Time frame: 4 weeks

  4. Change in overall quality of life (QOL)

    Change in QOL score as assessed by Kemp QOL (scale 1-7; with higher scores corresponding to higher quality of life)

    Time frame: 4 weeks

  5. Change in overall well-being

    Change in well-being score as assessed by World Health Organization 5 Well-being Index (WHO-5 Well-being Index; with higher scores corresponding to greater well-being)

    Time frame: 4 weeks

Other outcomes

  1. Change in pain

    Change in pain score as assessed by the Pain on average, Enjoyment of life, and General activity Score (PEG; scale 0-10 where 0 is no pain)

    Time frame: 4 weeks

  2. Change in Sleep quality

    Change in sleep quality (sleep disturbance) score as assessed by the PROMIS Sleep Disturbance 4A (scale 4 to 20; where higher scores correspond to higher levels of sleep disturbance)

    Time frame: 4 weeks

  3. Change in feelings of anxiety

    Change in anxiety score as assessed by the PROMIS Anxiety 4a (scale 4-20; where higher scores correspond to greater levels of anxiety)

    Time frame: 4 weeks

  4. Change in Stress

    Change in stress score as assessed by the PROMIS Stress 4a (scale 4-20; where higher scores correspond to greater levels of stress)

    Time frame: 4 weeks

07

Study locations

1 site
  • Radicle Science, Inc
    Del Mar, California 92014, United States
08

References and documents

Individual participant data

Plan to share: No — Data will not be shared with researchers outside of Radicle Collaborators on this study.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05502328
Lead sponsor
Radicle Science
Responsible party
Sponsor
First posted
Aug 16, 2022
Start date
Aug 17, 2022
Primary completion
Dec 31, 2022
Completion
May 24, 2023
Last update
Nov 22, 2023

Study contacts

Emily K Pauli, PharmD
principal investigator · Radicle Science, Inc

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion